Netherlands Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

    HPB, Vol. 25, Núm. 9, pp. 985-999

2021

  1. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells

    BMC Biology, Vol. 19, Núm. 1

  2. The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

    CardioVascular and Interventional Radiology, Vol. 44, Núm. 1, pp. 50-62

  3. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 11, pp. 2791-2800

2020

  1. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe

    Journal of Medical Screening, Vol. 27, Núm. 2, pp. 68-76

2018

  1. Chromosomes trapped in micronuclei are liable to segregation errors

    Journal of Cell Science, Vol. 131, Núm. 13

  2. Doxorubicin-induced DNA damage causes extensive ubiquitination of ribosomal proteins associated with a decrease in protein translation

    Molecular and Cellular Proteomics, Vol. 17, Núm. 12, pp. 2297-2308

2017

  1. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora

    Oncogene, Vol. 36, Núm. 13, pp. 1840-1848

2016

  1. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 24, pp. 4685-4699

2014

  1. Selection based on FOXA2 expression is not sufficient to enrich for dopamine neurons from human pluripotent stem cells

    Stem Cells Translational Medicine, Vol. 3, Núm. 9, pp. 1032-1042